大和授权项目,基于农业、林业和渔业部的“第一、第二和第三产业协作法”
Daiwa Authorized Project based on “Collaboration of Primary, Secondary, and Tertiary Industry Act” by MAFF
阅读中文说明与多语对照DAIWA NEWS & EVENTS
中文为主要阅读文字,英文官方内容作弱显示对照;内容与日本大和官网同步发布翻译。
Daiwa Authorized Project based on “Collaboration of Primary, Secondary, and Tertiary Industry Act” by MAFF
阅读中文说明与多语对照2nd Edition of BioBran Blue Book
阅读中文说明与多语对照Official Website Renewal
阅读中文说明与多语对照Exhibition: Health Food Expo, Ingredients and Contract Manufacture 2013
阅读中文说明与多语对照BioBran Seminar for Indonesian Medical Practitioners
阅读中文说明与多语对照Exhibition: 2013 Integrative Healthcare Symposium (DHD USA)
阅读中文说明与多语对照New Published Research Paper: Protective effect of low molecular fraction of MGN-3, a modified arabinoxylan from rice bran, on acute liver injury by inhibition of NF-κB and JNK/MAPK expression
阅读中文说明与多语对照NKCP Workshop 2013
阅读中文说明与多语对照New Published Research Paper: Suppressive Effect of Modified Arabinoxylan from Rice Bran (MGN-3) on D-Galactosamine- Induced IL-18 Expression and Hepatitis in Rats
阅读中文说明与多语对照Cancer in the Philippines (Daiwa’s Philippines Distributor)
阅读中文说明与多语对照New Published Research Paper: Arabinoxylan rice bran (MGN-3/Biobran) provides protection against whole-body γ-irradiation in mice via restoration of hematopoietic tissues
阅读中文说明与多语对照来源:大和药品株式会社日本官网;本站同步核对日期:2026-09-01;版权授权有效期至2030年5月31日。